U.S. Stock Futures Mixed as Beauty Health Company Reports Better-Than-Expected Q4 Revenue
March 13, 2024 6:16 AM | 2 min read
U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday. However, shares of The Beauty Health Company (SKIN) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter revenue results.
Beauty Health posted a quarterly loss of 7 cents per share, in-line with market estimates. The company’s quarterly sales came in at $96.80 million versus expectations of $87.63 million, according to data from Benzinga Pro. As a result, Beauty Health shares jumped 17.3% to $4.21 in pre-market trading.
In addition to Beauty Health, several other big stocks recorded gains in today’s pre-market trading session:
1. HUTCHMED (China) Limited (HCM) shares climbed 15% to $18.78 in pre-market trading after gaining 9% on Tuesday.
2. SIGA Technologies, Inc. (SIGA) gained 13.5% to $6.04 in pre-market trading after reporting a year-over-year increase in quarterly financial results.
3. BeiGene, Ltd. (BGNE) shares climbed 13% to $185.00 in pre-market trading.
4. MaxCyte, Inc. (MXCT) shares gained 10.5% to $4.40 in pre-market trading after reporting better-than-expected fourth-quarter financial results and issuing FY24 guidance.
5. Full Truck Alliance Co. Ltd. (YMM) climbed 10.2% to $7.67 in pre-market trading after announcing an extension of its share repurchase program up to $300 million.
6. Legend Biotech Corporation (LEGN) gained 9% to $71.00 in pre-market trading after an analyst initiated coverage with an Outperform rating and a price target of $86.
7. Clover Health Investments, Corp. (CLOV) climbed 8% to $0.8290 in pre-market trading after reporting better-than-expected fourth-quarter revenue results and issuing FY24 insurance revenue guidance.
8. United Natural Foods, Inc. (UNFI) gained 2.7% to $11.86 in pre-market trading.
Overall, it was a positive start for many companies in the pre-market trading session, with several stocks experiencing significant gains based on their latest financial results and market performance.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
